Skin formulation, preparation and uses thereof
Serum compositions for application to skin are described which contain an amniotic fluid extract in combination with embryonic stem cells. Formulations containing the serum composition are also described. The serum compositions and formulations may be applied to skin for treatment of symptoms of aging, wounds, burns, scars or other skin lesions. Methods of preparing the serum compositions and formulations are also disclosed.
1. A method of making a serum composition for application to the skin of a human in need thereof consisting essentially of:
a) incubating chicken eggs to form an embryoblast containing an embryo and amniotic fluid for 5-14 days;
b) extracting amniotic fluid from the eggs;
c) extracting the embryo from the eggs;
d) homogenizing the embryo or a portion thereof;
e) centrifuging the embryo to obtain an embryo supernatant and an embryo pellet;
f) mixing the amniotic fluid from step (b) with the embryo supernatant and the embryo pellet from step (e) at a ratio of 70-100% amniotic fluid and 0-30% embryo supernatant to provide an amniotic fluid/embryo supernatant/pellet;
g) adding at least one component selected from the group consisting of polyethylene glycol, hyaluronic acid, glycerin, soy protein, silk protein, ginko biloba, green tea extract, grape seed oil, rye seed extract, argireline, gluconodeltalactone, and sodium benzoate to said amniotic fluid/embryo supernatant/pellet to form said serum composition;
h) applying the serum composition to the skin of the human in need thereof.
2. The method of claim 1 , wherein the incubation period in step (a) is 7-8 days.